Canagliflozin attenuates the progression of atherosclerosis and inflammation process in APOE knockout mice.
Cardiovasc Diabetol
; 17(1): 106, 2018 07 26.
Article
in En
| MEDLINE
| ID: mdl-30049285
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Aorta
/
Aortic Diseases
/
Atherosclerosis
/
Canagliflozin
/
Sodium-Glucose Transporter 2 Inhibitors
/
Inflammation
Limits:
Animals
Language:
En
Journal:
Cardiovasc Diabetol
Journal subject:
ANGIOLOGIA
/
CARDIOLOGIA
/
ENDOCRINOLOGIA
Year:
2018
Type:
Article
Affiliation country:
Greece